Ameritas Investment Partners’s Merck MRK Stock Holding History

Ameritas Investment Partners’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$7.75M	Sell	64,435 -394	-0.6%	-$45.5K	0.24%	67
2025 Q4	$6.82M	Sell	64,829 -4,529	-7%	-$425K	0.21%	79
2025 Q3	$5.82M	Sell	69,358 -3,268	-4%	-$269K	0.18%	86
2025 Q2	$5.75M	Buy	72,626 +10,632	+17%	+$845K	0.18%	81
2025 Q1	$5.56M	Sell	61,994 -125	-0.2%	-$11.7K	0.19%	75
2024 Q4	$6.18M	Buy	62,119 +6,431	+12%	+$663K	0.2%	67
2024 Q3	$6.32M	Sell	55,688 -3,276	-6%	-$389K	0.21%	65
2024 Q2	$7.3M	Sell	58,964 -5,097	-8%	-$657K	0.25%	49
2024 Q1	$8.45M	Sell	64,061 -1,143	-2%	-$141K	0.29%	45
2023 Q4	$7.11M	Sell	65,204 -2,867	-4%	-$298K	0.26%	49
2023 Q3	$7.01M	Sell	68,071 -5,174	-7%	-$558K	0.28%	47
2023 Q2	$8.45M	Sell	73,245 -3,870	-5%	-$439K	0.32%	39
2023 Q1	$8.2M	Sell	77,115 -165	-0.2%	-$17.8K	0.32%	41
2022 Q4	$8.54M	Sell	77,280 -2,759	-3%	-$282K	0.34%	34
2022 Q3	$6.89M	Sell	80,039 -17,990	-18%	-$1.61M	0.31%	41
2022 Q2	$8.94M	Sell	98,029 -1,012	-1%	-$89.7K	0.39%	30
2022 Q1	$8.13M	Sell	99,041 -1,742	-2%	-$137K	0.29%	42
2021 Q4	$7.72M	Sell	100,783 -857	-0.8%	-$68.3K	0.26%	53
2021 Q3	$7.63M	Sell	101,640 -307	-0.3%	-$23.3K	0.28%	50
2021 Q2	$7.93M	Sell	101,947 -4,604	-4%	-$342K	0.28%	47
2021 Q1	$8.07M	Sell	106,551 -1,403	-1%	-$103K	0.31%	38
2020 Q4	$8.43M	Sell	107,954 -3,080	-3%	-$236K	0.39%	28
2020 Q3	$8.79M	Sell	111,034 -1,677	-1%	-$131K	0.4%	30
2020 Q2	$8.31M	Buy	112,711 +8,512	+8%	+$641K	0.4%	32
2020 Q1	$7.65M	Sell	104,199 -1,465	-1%	-$115K	0.43%	29
2019 Q4	$9.17M	Sell	105,664 -7,741	-7%	-$636K	0.41%	30
2019 Q3	$9.11M	Sell	113,405 -890	-0.8%	-$71.3K	0.42%	27
2019 Q2	$9.14M	Sell	114,295 -918	-0.8%	-$70.3K	0.42%	29
2019 Q1	$9.14M	Sell	115,213 -2,486	-2%	-$186K	0.43%	24
2018 Q4	$8.58M	Buy	117,699 +3,823	+3%	+$270K	0.47%	21
2018 Q3	$7.71M	Sell	113,876 -2,508	-2%	-$160K	0.36%	33
2018 Q2	$6.74M	Sell	116,384 -5,395	-4%	-$304K	0.32%	35
2018 Q1	$6.33M	Sell	121,779 -17,160	-12%	-$927K	0.3%	36
2017 Q4	$7.35M	Sell	138,939 -14,334	-9%	-$795K	0.33%	39
2017 Q3	$9.35M	Buy	153,273 +5,617	+4%	+$341K	0.44%	28
2017 Q2	$9.03M	Sell	147,656 -749	-0.5%	-$45.6K	0.44%	26
2017 Q1	$9M	Sell	148,405 -9,306	-6%	-$565K	0.45%	25
2016 Q4	$8.86M	Buy	157,711 +31,411	+25%	+$1.84M	0.45%	29
2016 Q3	$7.52M	Buy	126,300 +14,816	+13%	+$866K	0.41%	32
2016 Q2	$6.13M	Buy	111,484 +2,746	+3%	+$146K	0.4%	41
2016 Q1	$5.49M	Sell	108,738 -190	-0.2%	-$9.3K	0.36%	43
2015 Q4	$5.49M	Buy	108,928 +49	+0%	+$2.47K	0.37%	48
2015 Q3	$5.13M	Buy	108,879 +12,900	+13%	+$685K	0.37%	44
2015 Q2	$5.21M	Buy	95,979 +5	+0%	+$280	0.34%	48
2015 Q1	$5.26M	Buy	95,974 +3,015	+3%	+$171K	0.34%	48
2014 Q4	$5.04M	Buy	92,959 +1,984	+2%	+$111K	0.35%	50
2014 Q3	$5.14M	Sell	90,975 -4,211	-4%	-$236K	0.37%	45
2014 Q2	$5.25M	Sell	95,186 -910	-0.9%	-$49.6K	0.38%	45
2014 Q1	$5.21M	Sell	96,096 -3,151	-3%	-$163K	0.41%	45
2013 Q4	$4.74M	Sell	99,247 -10,588	-10%	-$484K	0.38%	50
2013 Q3	$4.99M	Buy	109,835 +64,911	+144%	+$2.96M	0.47%	36
2013 Q2	$1.99M	Buy	+44,924	New	+$2.01M	0.54%	55

Other funds holding MRK

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Ameritas Investment Partners's MRK Position: Q1 2026 in Review

Ameritas Investment Partners reduced its Merck (MRK) stake by 0.61% in Q1 2026, selling an estimated $45.5K and leaving 64,435 shares worth $7.75M. The position accounts for 0.24% of the portfolio, ranked #67.

Ameritas Investment Partners first reported a position in MRK in Q2 2013 and has held it in 52 quarters since. The position peaked at $9.35M in Q3 2017. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

Ameritas Investment Partners held 64,435 shares of Merck worth $7.75M as of Q1 2026.
Ameritas Investment Partners sold 394 Merck shares in Q1 2026, an estimated $45.5K.
Merck made up 0.24% of Ameritas Investment Partners's portfolio in Q1 2026, its #67 holding.
Ameritas Investment Partners first reported a position in Merck in Q2 2013 and has held it in 52 quarters since.
Ameritas Investment Partners's Merck position peaked at $9.35M in Q3 2017.
3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Ameritas Investment Partners's 13F filing for Q1 2026, filed 13 May 2026.